Low-dose MR prednisone chronotherapy has an important clinical effect ... This duration is sufficient to demonstrate the initial benefits achieved by adding MR prednisone to DMARD treatment, including ...

Introduction Acute exacerbation of interstitial lung disease (AE-ILD) often results in death and poses significant challenges ...

Results Proportion of patients experiencing a flare was significantly lower in the maintenance group as compared with the withdrawal group (4 patients vs 17; RR 0.2 (95% CI 0.1 to 0.7), p=0.003).

Indeed, numerous items, including the benefit/risk ratio of low-dose and very low-dose GCs and optimal duration of GCs as bridging therapy, remain on the research agenda, and future studies are needed ...

Our results support the hypothesis that a low initial dose of prednisone is sufficient to control PMR in the majority of patients. They also suggest that 0.20 mg per kg weight could be the ...

This was the first study to give evidence of benefit of systemic low-dose corticosteroids with and without an antihistamine in patients with acute exacerbations of allergic rhinitis. The aim of ...

42.2% were on background methotrexate (MTX); and 5.2% took concomitant low-dose prednisone. After withdrawal of TNFi treatment, 146 (44.9%) patients lost clinical benefit due to: increased CDAI (31.5% ...

The benefits of high (30 mg) versus low (15 mg) dose UPA as maintenance treatment in UC remains to be established. Methods Pts with a clinical response after 8 weeks of UPA 45 mg once daily (OD) ...

If you are using the liquid form of this medication, carefully measure the dose using a special measuring ... because your doctor has judged that the benefit to you is greater than the risk ...

Background: Previous studies have indicated the benefits of adding long acting β 2 agonists ... Conclusions: Adding eformoterol to a low or moderate dose of budesonide in mild asthma resulted in ...

Conclusion: These results suggest that 50–60 mg daily prednisone followed by lower doses (10 mg or less) has the benefit of resolving ptosis and diplopia that lasts for at least 2 years in ...